Ignacio Alberca

1.2k total citations
40 papers, 818 citations indexed

About

Ignacio Alberca is a scholar working on Hematology, Internal Medicine and Immunology. According to data from OpenAlex, Ignacio Alberca has authored 40 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 9 papers in Internal Medicine and 8 papers in Immunology. Recurrent topics in Ignacio Alberca's work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Platelet Disorders and Treatments (7 papers). Ignacio Alberca is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (14 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Platelet Disorders and Treatments (7 papers). Ignacio Alberca collaborates with scholars based in Spain, Russia and United States. Ignacio Alberca's co-authors include Vicente Vicente, José Ramón González‐Porras, Ramón Montes, José Hermida, A. López Borrasca, Alberto Orfao, José Francisco Tomás, María Dolores Tabernero, Javier Corral and Rocío Gónzález‐Conejero and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and American Journal of Kidney Diseases.

In The Last Decade

Ignacio Alberca

36 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Alberca Spain 18 495 250 150 144 118 40 818
Αnthi Travlou Greece 18 384 0.8× 145 0.6× 189 1.3× 115 0.8× 40 0.3× 39 840
Mariateresa Pugliano Italy 12 464 0.9× 181 0.7× 361 2.4× 123 0.9× 31 0.3× 22 868
HP Schwarz Austria 15 489 1.0× 105 0.4× 92 0.6× 147 1.0× 27 0.2× 40 962
G. D. Qureshi United States 10 279 0.6× 89 0.4× 154 1.0× 68 0.5× 39 0.3× 21 737
Helen Ireland United Kingdom 20 500 1.0× 253 1.0× 260 1.7× 140 1.0× 11 0.1× 30 1.1k
B. Bottasso Italy 21 677 1.4× 276 1.1× 283 1.9× 412 2.9× 12 0.1× 38 1.5k
Sourav K. Kundu United States 9 510 1.0× 246 1.0× 567 3.8× 53 0.4× 20 0.2× 15 996
C. Kluft Netherlands 15 251 0.5× 68 0.3× 125 0.8× 64 0.4× 13 0.1× 35 751
Henk J Adriaansen Netherlands 13 250 0.5× 60 0.2× 177 1.2× 91 0.6× 21 0.2× 29 665
DaLi Feng United States 17 289 0.6× 133 0.5× 623 4.2× 34 0.2× 18 0.2× 27 1.0k

Countries citing papers authored by Ignacio Alberca

Since Specialization
Citations

This map shows the geographic impact of Ignacio Alberca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Alberca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Alberca more than expected).

Fields of papers citing papers by Ignacio Alberca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Alberca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Alberca. The network helps show where Ignacio Alberca may publish in the future.

Co-authorship network of co-authors of Ignacio Alberca

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Alberca. A scholar is included among the top collaborators of Ignacio Alberca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Alberca. Ignacio Alberca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Labrador, Jorge, Lucía López‐Corral, Oriana López‐Godino, et al.. (2014). Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. Bone Marrow Transplantation. 49(5). 684–690. 39 indexed citations
2.
González‐Porras, José Ramón, Fernando Escalante, Emilia Pardal, et al.. (2013). Safety and efficacy of splenectomy in over 65‐yrs‐old patients with immune thrombocytopenia. European Journal Of Haematology. 91(3). 236–241. 47 indexed citations
3.
Labrador, Jorge, Lucía López‐Anglada, Francisco S. Lozano, et al.. (2012). Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients. Haematologica. 98(3). 437–443. 53 indexed citations
4.
Pérez-Andreu, Virginia, Vanessa Roldán, María Fernanda López Fernández, et al.. (2010). Pharmacogenetics of acenocoumarol in patients with extreme dose requirements. Journal of Thrombosis and Haemostasis. 8(5). 1012–1017. 18 indexed citations
5.
Pérez-Simón, Josè Antonio, Soraya Tabera, María Eugenia Sarasquete, et al.. (2009). Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura. Cytotherapy. 11(6). 698–705. 56 indexed citations
6.
Pérez-Simón, Josè Antonio, Soraya Tabera, María Eugenia Sarasquete, et al.. (2009). Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura. Cytotherapy. 1–8. 6 indexed citations
7.
8.
Hernández-Campo, Pilar, Júlia Almeida, Maria Acevedo-Calado, et al.. (2008). Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria. Transfusion. 48(7). 1403–1414. 22 indexed citations
9.
Corral, Javier, David Hernández‐Espinosa, Rocío Gónzález‐Conejero, et al.. (2007). Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood. 109(10). 4258–4263. 72 indexed citations
10.
González‐Porras, José Ramón, Francisco Martín‐Herrero, Ramón García‐Sánz, et al.. (2006). Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism. Thrombosis Research. 119(6). 691–698. 4 indexed citations
11.
Montes, Ramón, et al.. (2006). The c.−1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients. British Journal of Haematology. 133(2). 183–187. 44 indexed citations
12.
González‐Porras, José Ramón, Ramón García‐Sánz, Ignacio Alberca, et al.. (2005). Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. Blood Coagulation & Fibrinolysis. 17(1). 23–28. 27 indexed citations
13.
Pérez‐Ceballos, Elena, Javier Corral, Ignacio Alberca, et al.. (2002). Prothrombin A19911G and G20210A polymorphisms' role in thrombosis. British Journal of Haematology. 118(2). 610–614. 28 indexed citations
14.
15.
Alberca, Ignacio, et al.. (1999). Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: Effects of Tween 20 and relationship with antibodies to ?2-glycoprotein I. Journal of Clinical Laboratory Analysis. 13(2). 59–64. 17 indexed citations
16.
17.
Estellés, Amparo, et al.. (1989). Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism. Thrombosis Research. 56(4). 565–570. 26 indexed citations
18.
Dios, Isabel De, et al.. (1986). Detection of anomalies in cell-surface carbohydrates on thrombasthenic platelets using 125I-labeled lectins. Annals of Hematology. 52(2). 91–97. 1 indexed citations
19.
Vicente, Vânia Aparecida, Ignacio Alberca, M.S. Castro, & A. López Borrasca. (1986). Mode of inheritance of type II protein S deficiency [letter]. Blood. 68(6). 1415–1415. 1 indexed citations
20.
Miguel, Jesús F. San, et al.. (1982). [Hypogammaglobulinemia and multiple myeloma].. PubMed. 162(3-4). 123–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Αnthi Travlou Breakdown of academic impact, for papers by Mariateresa Pugliano Breakdown of academic impact, for papers by HP Schwarz Breakdown of academic impact, for papers by G. D. Qureshi Breakdown of academic impact, for papers by Helen Ireland Breakdown of academic impact, for papers by B. Bottasso Breakdown of academic impact, for papers by Sourav K. Kundu Breakdown of academic impact, for papers by C. Kluft Breakdown of academic impact, for papers by Henk J Adriaansen Breakdown of academic impact, for papers by DaLi Feng
Rankless by CCL
2026